359 Interleukin-17F expression in psoriasis and health

Jingshu Xu; Silvia Bulfone‐Paus; A. Maroof; Christopher Em Griffiths; Richard B. Warren

doi:10.1016/j.jid.2019.07.361

Discussion(0)

No comments yet. Be the first to comment.

Related publications

Article2013

Interleukin 17F Level and Interferon Beta Response in Patients With Multiple Sclerosis

Hans Hartung, Lawrence Steinman, Douglas S. Goodin, Giancarlo Comi, Stuart D. Cook, Massimo Filippi, Paul O’Connor, Douglas Jeffery, Ludwig Kappos, Robert C. Axtell, Volker Knappertz, Timon Bogumil, Susanne Schwenke, Ed Croze, Rupert Sandbrink, Christopher Pohl

Article2019

AB0738 DUAL NEUTRALISATION OF INTERLEUKIN (IL)–17A AND IL–17F WITH BIMEKIZUMAB IN MODERATE-TO-SEVERE PLAQUE PSORIASIS: 60-WEEK RESULTS FROM A RANDOMISED, DOUBLE-BLINDED, PHASE 2B EXTENSION STUDY

Andrew Blauvelt, Kim Papp, Joseph F. Merola, Alice B. Gottlieb, Nancy Cross, Cynthia Madden, Maggie Haitian Wang, Christopher L. Cioffi, Christopher Em Griffiths

Editorial Material2015

Interleukin 17-A inhibition in the treatment of psoriasis

Zenas Z N Yiu, Christopher Em Griffiths

Article1998

Calcipotriene-induced improvement in psoriasis is associated with reduced interleukin-8 and increased interleukin-10 levels within lesions

Kang, Yi ̆, Christopher Em Griffiths, Fancher, Hamilton, Choi

Article2014

Whole blood gene expression and interleukin-6 levels

Honghuang Lin, Roby Joehanes, Luke C. Pilling, Josée Dupuis, Kathryn L. Lunetta, Sai-Xia Ying, Emelia Benjamin, Dena Hernandez, Andrew Singleton, David Melzer, Peter J. Munson, Daniel Levy, Luigi Ferrucci, Joanne M. Murabito